Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
RETROSPECTIVE ANALYSIS OF ER, PR & HER 2/ NEU RECEPTOR STATUS IN RELATION TO PROGNOSTIC OUTCOME OF BREAST CARCINOMA PATIENTS
Ist Teil von
INDIAN JOURNAL OF APPLIED RESEARCH, 2023-08, p.56-58
Erscheinungsjahr
2023
Beschreibungen/Notizen
The study was done retrospectively on 50 patients of breast cancer to establish association between ER, PR status,
HER2/neu overexpression, clinical features and tumour histopathology, and to effectively use these parameters to
prognosticate and treat breast cancer patients. We found that ER, PR combined is a good prognostic indicator for carcinoma breast while
HER2/neu cannot be used individually for prognosticating the outcome in women with carcinoma breast. But when HER2/neu is combined with
ER and PR, we found worst outcome in women having triple negative (ER -, PR -, HER2/neu -) status and best outcome is seen in women with
triple positive (ER +, PR +, HER2/neu +) status.